Information:
Fel:
ID
12470
Beskrivning
The purpose of this trial is to evaluate the safety and indicators of efficacy of up to 4 doses of orally administered dabigatran etexilate, administered twice daily, compared to placebo when given in addition to dual antiplatelet treatment in patients with an index event (MI) at high risk for new ischaemic cardiovascular events. https://www.clinicaltrials.gov/ct2/show/NCT00621855
Länk
https://www.clinicaltrials.gov/ct2/show/NCT00621855
Nyckelord
Versioner (2)
- 2015-07-28 2015-07-28 -
- 2015-11-21 2015-11-21 -
Uppladdad den
21 november 2015
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility RE-DEEM Acute Coronary Syndrome NCT00621855
Similar models
Eligibility criteria
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Acute coronary syndrome
Item
Patients with acute coronary syndromes
boolean
C0948089 (UMLS CUI [1])
Cardiac risk factor
Item
with at least one additional risk factor for cardiovascular complications
boolean
C0741920 (UMLS CUI-1)
Oral Anticoagulants
Item
Long term treatment with any other oral anticoagulant
boolean
C0354604 (UMLS CUI-1)
Stroke
Item
Severe/disabling stroke within last 6 months
boolean
C0038454 (UMLS CUI-1)
Bleeding risk
Item
Conditions associated with increased bleeding risk
boolean
C3251812 (UMLS CUI-1)
Anaemia
Item
Anaemia
boolean
C0002871 (UMLS CUI-1)
Thrombocytopenia
Item
Thrombocytopenia
boolean
C0040034 (UMLS CUI-1)
Kidney failure
Item
Severe renal impairment
boolean
C0035078 (UMLS CUI-1)
Liver failure
Item
Liver disease
boolean
C0085605 (UMLS CUI-1)
Pregnancy
Item
Positive pregnancy test
boolean
C0549206 (UMLS CUI-1)